
    
      Part 1: This part will be conducted in 5 dose ascending cohorts, including 1 single dose
      accelerated titration design pilots and 4 multiple dose escalation groups. Descriptive
      statistics will be used to summarize data.

      Part 2: This part will only include the part 1 recommended dose. Hypothesis test and
      descriptive statistics will be used to summarize data.
    
  